European Journal of Endocrinology · 2000 · 13 citations · 29 references
MedicineEndocrinologyPharmacologyDiabetologyMetabolic RegulationNeuroendocrinologyDiabetes MellitusGlucose HomeostasisGlycemic ControlInsulin TherapyBlood Glucose RegulationGlucagon BiosynthesisGlucagon PhysiologyGlucagon Secretion RegulationGlucagon-like PeptidesGlucose Infusion RateGlucose-stimulated Insulin Secretion
OBJECTIVE: To evaluate if insulin has a suppressive effect on the glucagon secretion stimulated by arginine in type 1 diabetes. RESEARCH DESIGN AND METHODS: The alpha-cell response to an i.v. bolus of arginine (150mgkg(-1)) followed by an infusion of arginine (10mgkg(-1)min(-1)) was studied in random order during either low dose infusion (LDT) or high dose infusion (HDT) of insulin in ten patients with type 1 diabetes. The blood glucose level was clamped at an arterialized level of 5mmoll(-1) by a variable infusion of glucose. Venous C-peptide, glucagon, growth hormone, and insulin were analyzed. RESULTS: The mean plasma concentration of insulin was four times higher during the HDT. The C-peptide level did not differ between the LDT and the HDT. During the LDT in response to arginine the blood glucose level increased from 5.0 to 5.8mmol l(-1) although the glucose infusion was markedly reduced, while no change was seen during the HDT. A significantly smaller increase in the glucagon levels during the HDT was seen (area under the curve of 413+/-45 vs 466+/-44pgml(-1)h(-1), P=0.03) while the growth hormone levels were almost identical. CONCLUSION: This study demonstrates that a high level of circulating insulin exerts an inhibitory effect on the glucagon response to arginine in type 1 diabetes. Thus, the suppressive effect of insulin on the glucagon release from the alpha-cell seems to be general and not only dependent on stimulation by hypoglycemia.
29
Radioimmunological determination of human C-peptide in serum
Lise G. Hedïng · Diabetologia · 1975 · 836 citations · Full text
Interplay of Nutrients and Hormones in the Regulation of Insulin Release*
Daniël Pipeleers, F. C. SCHUIT, Pieter In 'T Veld et al. · Endocrinology · 1985 · 358 citations
Insulin within islets is a physiologic glucagon release inhibitor.
Hiroshi Maruyama, Akitaka Hisatomi, Lelio Orci et al. · Journal of Clinical Investigation · 1984 · 296 citations · Full text